These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1676643)

  • 1. Metabolism of the antipsychotic drug tiospirone in humans.
    Mayol RF; Jajoo HK; Klunk LJ; Blair IA
    Drug Metab Dispos; 1991; 19(2):394-9. PubMed ID: 1676643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of in vitro metabolites of the antipsychotic drug tiospirone by mass spectrometry.
    Jajoo HK; Blair IA; Klunk LJ; Mayol RF
    Biomed Environ Mass Spectrom; 1990 May; 19(5):281-5. PubMed ID: 2340363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the antianxiety drug buspirone in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1989; 17(6):634-40. PubMed ID: 2575499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the antianxiety drug buspirone in the rat.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1989; 17(6):625-33. PubMed ID: 2575498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
    Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH
    Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
    Mutlib AE; Jurcak J; Hrib N
    Drug Metab Dispos; 1996 Oct; 24(10):1139-50. PubMed ID: 8894517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the novel benzisothiazole ring-cleaved products of the antipsychotic drug ziprasidone.
    Prakash C; Kamel A; Cui D
    Drug Metab Dispos; 1997 Jul; 25(7):897-901. PubMed ID: 9224786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of bepridil in laboratory animals and humans.
    Wu WN; Hills JF; Chang SY; Ng KT
    Drug Metab Dispos; 1988; 16(1):69-77. PubMed ID: 2894958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
    Colizza K; Awad M; Kamel A
    Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.